Mago, Cherry Mae Q.
HRN: 12-61-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2023
CEFUROXIME 1.5GM (VIAL)
11/06/2023
11/12/2023
IV
1.5 Grams
Q8
CS
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes